Review Article
Volume 5 Issue 3 - 2022
The Numerous and Varied Applications of Spirulina in Medical Practice
Nicholas A Kerna1,2*, Uzoamaka Nwokorie3, Mary Ann Christy Ortigas4, Sudeep Chawla5, Kevin D Pruitt6,7, John V Flores8,9, Hilary M Holets8,9, ND Victor Carsrud10, Shain Waugh11 and Joseph Anderson II12
1SMC–Medical Research, Thailand
2First InterHealth Group, Thailand
3University of Washington, USA
4University of Nevada, Las Vegas, USA
5Chawla Health & Research, USA
6Kemet Medical Consultants, USA
7PBJ Medical Associates, LLC, USA
8Beverly Hills Wellness Surgical Institute, USA
9Orange Partners Surgicenter, USA
10Lakeline Wellness Center, USA
11Fettle Path, USA
12International Institute of Original Medicine, USA
*Corresponding Author: Nicholas A Kerna, (mailing address) POB47 Phatphong, Suriwongse Road, Bangkok, Thailand 10500.
Received: October 30, 2021; Published: February 28, 2022




Abstract

Spirulina is a cyanobacteria (blue-green alga) rich in vital nutrients, having tremendous potential as a “future food”. The utility of algae is not limited to providing nutrition. Specific alga can perform the following functions: immunomodulator, anti-allergic, cleanses the body of toxins, antitumor, anti-inflammatory, antiviral, and abstergent (cleansing the body of toxins). Spirulina has been a vital dietary component for humans for millennia. The United Nations recognizes Spirulina as a potential defense against malnutrition. The current evidence in support of Spirulina points towards perfoming further research regarding the promising applications of Spirulina. These organisms are a rich source of bioactive compounds and, thus, should be considered as an alternative and supplementary therapy—albeit with scientific support and evidence-based studies. The revolution in functional foods continues as the incidence of lifestyle-related diseases is increasing. The most notable experiments have been conducted in studying Spirulina’s effect on metabolic disorders, revealing its ability to reduce cholesterol, triglycerides, and blood glucose. Also, Spirulina has particular applications in cancer research, protecting against the adverse effects of specific chemotherapeutic agents. Microalgae can also form special supplements for vegetarians, offsetting the absence of protein in the vegan diet.

Nevertheless, Spirulina also has a negative side and potential adverse effects. Self-medication with Spirulina supplements can lead to unwanted complications if a person is taking immunosuppressants or anticoagulants concomitantly or suffering from autoimmune diseases. Children and pregnant women should avoid these products until more applicable data are obtained. Also, some people may have an inherent allergy to algal products.

Keywords: Cyanobacteria; Diabetes Mellitus; Functional Food; Hypertension; Metabolic Syndrome; Microalgae; Nutritional Supplement; Phytochemicals; Phytosterols; Pseudovitamin; Zoochemical

References

  1. Anis M., et al. “Algae as nutrition, medicine and cosmetic: The forgotten history, present status, and future trends”. World Journal of Pharmacy and Pharmaceutical Sciences6 (2017): 1934-1959. https://www.researchgate.net/publication/317335947_Algae_as_nutrition_medicine_and_cosmetic_The_forgotten_history_present_status_and_future_trends
  2. Siva Kiran RR., et al. “Spirulina in combating Protein Energy Malnutrition (PEM) and Protein Energy Wasting (PEW) - A review (2016). https://www.researchgate.net/publication/294880629_Spirulina_in_combating_Protein_Energy_Malnutrition_PEM_and_Protein_Energy_Wasting_PEW_-_A_review
  3. Ugwu CU., et al. “Photobioreactors for mass cultivation of algae”. Bioresource Technology 99 (2018): 4021e4028. https://www.sciencedirect.com/science/article/abs/pii/S0960852407001368
  4. Karkos PD., et al. “Spirulina in Clinical Practice: Evidence-Based Human Applications”. Evidence-Based Complementary and Alternative Medicine (2011): 531053. https://www.hindawi.com/journals/ecam/2011/531053/?utm_source=google&utm_medium=cpc&utm_campaign=HDW_MRKT_GBL_SUB_ADWO_PAI_DYNA_JOUR_X&gclid=EAIaIQobChMIuZi-jK6c9QIViWkqCh0UbQSVEAAYASAAEgKF_vD_BwE
  5. Siva Kiran RR., et al. “Spirulina in combating Protein Energy Malnutrition (PEM) and Protein Energy Wasting (PEW) - A review”. Nutrition Research Journal 1 (2015): 62-79. https://www.semanticscholar.org/paper/Spirulina-in-combating-Protein-Energy-Malnutrition-Rr-Madhu/ec2626590a49026ec2c0d8824c0121ae54900dda
  6. Sánchez M., et al. “Spirulina (Arthrospira): an edible microorganism: a review”. Universitas Scientiarum1 (2003): 7-24. https://www.researchgate.net/publication/292588254_Spirulina_Arthrospira_An_edible_microorganism_A_review
  7. Habib MAB., et al. “A review on culture, production and use of Spirulina as food for humans and feeds for domestic animals and fish. Food And Agriculture Organization of The United Nations (2021). https://www.fao.org/3/i0424e/i0424e00.htm
  8. Islam JMM., et al. “Boosting the Food Functionality (In VivoandIn Vitro) of Spirulina by Gamma Radiation: An Inspiring Approach”. International Journal of Food Engineering 4 (2015): 579-585. https://www.degruyter.com/document/doi/10.1515/ijfe-2014-0342/html
  9. Arora R., et al. “Spirulina - From growth to nutritional product: A review”. Trends in Food Science and Technology 69 (2017): 157e171. https://www.sciencedirect.com/science/article/abs/pii/S0924224417302182
  10. Piccolo A. “Spirulina – a livelihood and a business venture (2021). https://www.fao.org/documents/card/en/c/fcfbb587-ac0a-4ceb-9a37-6ab2f79bd5c3/
  11. Dineshkumar R., et al. “Cultivation of Spirulina platensis in selective media”. Indian Journal of GeoMarine Sciences12 (2016): 1749-1754. https://www.researchgate.net/publication/329782935_Cultivation_of_Spirulina_platensis_in_different_selective_media
  12. Piccolo A. “Spirulina – a livelihood and a business venture (2021). https://cupdf.com/document/spirulina-a-livelihood-and-a-business-venture.html
  13. Michael A., et al. “Biomass and nutritive value of Spirulina (Arthrospira fusiformis) cultivated in a cost-effective medium”. Annals of Microbiology 69 (2019): 1387-1395. https://annalsmicrobiology.biomedcentral.com/articles/10.1007/s13213-019-01520-4
  14. Mathur M. “Bioactive Molecules of Spirulina: A Food Supplement”. In: Mérillon JM., Ramawat K. (editions) Bioactive Molecules in Food. Reference Series in Phytochemistry. Springer, Cham (2018). https://www.researchgate.net/publication/326296216_Bioactive_Molecules_of_Spirulina_A_Food_Supplement
  15. Tarantino LM. “Agency Response Letter GRAS Notice No”. GRN000127. FDA Home page (2003). https://www.fda.gov/food/gras-notice-inventory/agency-response-letter-gras-notice-no-grn-000623
  16. Federal Register. Rules and Regulations 78.156 (2013).
  17. DiNicolantonio JJ., et al. “Effects of Spirulina on weight loss and blood lipids: a review”. Open Heart 7 (2020): e001003. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061888/
  18. Seyidoglu N., et al. “A Prominent Superfood: Spirulina platensis, Superfood and Functional Food - The Development of Superfoods and Their Roles as Medicine, Naofumi Shiomi and Viduranga Waisundara, Intech Open (2017). https://www.intechopen.com/chapters/52913
  19. Fithriani D Sinurat E. “2019 IOP Conf. Ser.: Earth Environ. Sci. (2019): 278 012028.
  20. Nicoletti M. “Microalgae Nutraceuticals”. Foods3 (2016): 54. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302390/
  21. Prates JAM mateus CMRP. “Functional foods from animal sources and their physiologically active components”. The Revue de Médecine Vétérinaire 3 (2002): 155-160. https://www.researchgate.net/publication/296637187_Functional_foods_from_animal_sources_and_their_physiologically_active_components
  22. Sahina OI. “Effect of Spirulina Biomass Fortification for Biscuits and Chocolates”. Turkish Journal of Agriculture - Food Science and Technology4 (2019): 583-587. http://agrifoodscience.com/index.php/TURJAF/article/view/2204
  23. Seghiri R., et al. “Functional Composition, Nutritional Properties, and Biological Activities of Moroccan Spirulina Microalga Journal of Food Quality Volume (2019). https://www.researchgate.net/publication/334225916_Functional_Composition_Nutritional_Properties_and_Biological_Activities_of_Moroccan_Spirulina_Microalga
  24. Trautwein EA and Demonty I. “Phytosterols: natural compounds with established and emerging health benefits”. OCL5 (2007): 259-266. https://www.ocl-journal.org/articles/ocl/pdf/2007/05/ocl2007145p259.pdf
  25. Torres-Duran PV., et al. “Antihyperlipidemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report”. Lipids in Health and Disease (2007). https://pubmed.ncbi.nlm.nih.gov/18039384/
  26. Parikh P., et al. “Role of Spirulina in the Control of Glycemia and Lipidemia in Type 2 Diabetes Mellitus”. Journal of Medicinal Food Winter 4 (2001): 193-199. https://pubmed.ncbi.nlm.nih.gov/12639401/
  27. Nagaoka S., et al. “A novel protein C-phycocyanin plays a crucial role in the hypocholesterolemic action of Spirulina platensis concentrate in rats”. Journal of Nutrition 135 (2005): 2425-2430. https://www.researchgate.net/publication/7587163_A_Novel_Protein_C-Phycocyanin_Plays_a_Crucial_Role_in_the_Hypocholesterolemic_Action_of_Spirulina_platensis_Concentrate_in_Rats
  28. Li-Kun H., et al. “Isolation of pancreatic lipase activity-inhibitory component of Spirulina platensis reduces postprandial triacylglycerolemia”. Yakugaku Zasshi 126 (2006): 43-49. https://www.researchgate.net/publication/7376357_Isolation_of_Pancreatic_Lipase_Activity-inhibitory_Component_of_Spirulina_Platensis_and_It_Reduce_Postprandial_Triacylglycerolemia
  29. Guan Y., et al. “Analysis of the contents of elements in Spirulina from different producing areas 27 (2007): 1029-1031. https://pubmed.ncbi.nlm.nih.gov/17655131/
  30. Hernández Lepe MA., et al. “Spirulina and its hypolipidemic and antioxidant effects in humans: a systematic review]”. Nutricion Hospitalaria 32 (2015): 494-500. https://pubmed.ncbi.nlm.nih.gov/26268076/
  31. Huang H., et al. “Quantifying the effects of Spirulina supplementation on plasma lipid and glucose concentrations, body weight, and blood pressure”. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 11 (2018): 729-742. https://www.researchgate.net/publication/328924205_Quantifying_the_effects_of_spirulina_supplementation_on_plasma_lipid_and_glucose_concentrations_body_weight_and_blood_pressure
  32. Yousefi R., et al. “Spirulina platensis effectively ameliorates anthropometric measurements and obesity-related metabolic disorders in obese or overweight healthy individuals: a randomized controlled trial”. Complementary Therapies in Medicine 40 (2018): 106-112. https://pubmed.ncbi.nlm.nih.gov/30219433/
  33. Hayashi K., et al. “A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities”. AIDS Research and Human Retroviruses 15 (1996): 1463-1471. https://pubmed.ncbi.nlm.nih.gov/8893054/
  34. Patel S and Goyal A. “Current and prospective insights on food and pharmaceutical applications of Spirulina”. Current Trends in Biotechnology and Pharmacy2 (2013): 696-707. https://www.researchgate.net/publication/236208201_Current_and_prospective_insights_on_food_and_pharmaceutical_applications_of_spirulina
  35. Mathew B., et al. “Evaluation of chemoprevention of oral cancer with Spirulina fusiformis”. Nutrition and Cancer2 (1995): 197-202. https://pubmed.ncbi.nlm.nih.gov/8584455/
  36. Gupta S., et al. “Spirulina protects against Rosiglitazone-induced osteoporosis in insulin resistance rats”. Diabetes Research and Clinical Practice 87 (2010): 38-43. https://pubmed.ncbi.nlm.nih.gov/19896232/
  37. Jiang L., et al. “Phycocyanin: A Potential Drug for Cancer Treatment”. Journal of Cancer 17 (2017): 3416-3429. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687155/
  38. Zozulia IS and Iurchenko AV. “The adaptive potentials of those who worked in the cleanup of the accident's aftermath at the Chernobyl Atomic Electric Power Station under the influence of different treatment methods”. Lik Sprava 3-4 (2000): 18-21. https://pubmed.ncbi.nlm.nih.gov/10921251/
  39. Salazar M., et al. “Subchronic toxicity study in mice fed Spirulina maxima”. Journal of Ethnopharmacology 3 (1998): 235-241. https://europepmc.org/article/med/9849634
  40. Mishra T., et al. “Spirulina: the beneficial algae”. International Journal of Applied Microbiology Science3 (2013): 21-35. https://www.researchgate.net/publication/339617444_SPIRULINA_THE_BENEFICIAL_ALGAE
  41. Piñero Estrada JE., et al. “Antioxidant activity of different fractions of Spirulina platensis protean extract”. Farmaco 56 (2001): 497-500. https://www.researchgate.net/publication/11859882_Antioxidant_activity_of_different_fractions_of_Spirulina_platensis_protean_extract_Il
  42. Yang HN., et al. “Spirulina platensis inhibits anaphylactic reaction”. Life Sciences 13 (1997): 1237-1244. https://khu.elsevierpure.com/en/publications/spirulina-platensis-inhibits-anaphaylactic-reaction
  43. Hayashi T., et al. “Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis”. Journal of Natural Products 1 (1996): 83-87. https://pubs.acs.org/doi/10.1021/np960017o
  44. Reddy MC., et al. “C-Phycocyanin, a selective cyclooxygenase-2 inhibitor, induces apoptosis in lipopolysaccharide-stimulated RAW 264.7 macrophages”. Biochemical and Biophysical Research Communications 2 (2003): 385-392. https://europepmc.org/article/med/12711327
  45. Mazokopakis EE., et al. “The hepatoprotective and hypolipidemic effects of Spirulina (Arthrospira platensis) supplementation in a Cretan population with non-alcoholic fatty liver disease: a prospective pilot study”. Annals of Gastroenterology 4 (2014): 387-394. https://pubmed.ncbi.nlm.nih.gov/25331487/
  46. Kalafati M., et al. “Ergogenic and antioxidant effects of Spirulina supplementation in humans”. Medicine and Science in Sports and Exercise 1 (2010): 142-151. https://pubmed.ncbi.nlm.nih.gov/20010119/
  47. Nourollahian M., et al. “Clinical comparison of the efficacy of Spirulina platensis and cetirizine for the treatment of allergic rhinitis”. ACTA Otorhinolaryngologica Italica 3 (2020): 224-229. https://pubmed.ncbi.nlm.nih.gov/32773785/
  48. Karkos PD., et al. “Complementary ENT': a systematic review of commonly used supplements”. The Journal of Laryngology and Otology 8 (2007): 779-782. https://pubmed.ncbi.nlm.nih.gov/17125579/
  49. Fox RD. “Spirulina: The Alga That Can End Malnutrition”. Futurist 1 (1985): 30-35. https://eric.ed.gov/?id=EJ310656
  50. Simpore J., et al. “Nutrition rehabilitation of HIV-infected and HIV-negative undernourished children utilizing Spirulina”. Annals of Nutrition and Metabolism 6 (2005): 373-865. https://pubmed.ncbi.nlm.nih.gov/16219988/
  51. James R., et al. “Effect of dietary Spirulina level on growth, fertility, coloration and leucocyte count in red swordtail, xiphophorus helleri”. The Israeli Journal of Aquaculture2 (2006): 97-104. https://www.researchgate.net/publication/279888176_Effect_of_dietary_Spirulina_level_in_growth_fertility_coloration_and_leucocyte_count_in_red_swordtail_Xiphophorus_helleri
  52. Syarina P., et al. “Wound healing potential of Spirulina platensis extracts on human dermal fibroblast cells”. EXCLI Journal 14 (2015): 385-393. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800779/
  53. Karadeniz A., et al. “Spirulina platensis protects against gentamicin-induced nephrotoxicity in rats”. Phytotherapy Research11 (2008): 1506-1510. https://www.researchgate.net/publication/23159361_Spirulina_platensis_Protects_against_Gentamicin-induced_Nephrotoxicity_in_Rats
  54. Khan M., et al. “Protective effect of Spirulina against doxorubicin-induced cardiotoxicity”. Phytotherapy Research: PTR12 (2005): 1030-1037. https://pubmed.ncbi.nlm.nih.gov/16372368/
  55. Wang Y., et al. “Dietary supplementation with blueberries, spinach, or Spirulina reduces ischemic brain damage”. Experimental Neurology 1 (2005): 75-84. https://www.sciencedirect.com/science/article/abs/pii/S0014488604004923
  56. Finamore A., et al. “Antioxidant, Immunomodulating, and Microbial-Modulating Activities of the Sustainable and Ecofriendly Spirulina”. Oxidative Medicine and Cellular Longevity (2017): 3247528. https://pubmed.ncbi.nlm.nih.gov/28182098/
  57. Choi JH., et al. “Spirulan from blue-green algae inhibits fibrin and blood clots: its potent antithrombotic effects”. The Journal of Biochemical and Molecular Toxicology 5 (2015): 240-248. https://www.researchgate.net/publication/272074580_Spirulan_from_Blue-Green_Algae_Inhibits_Fibrin_and_Blood_Clots_Its_Potent_Antithrombotic_Effects
  58. Jensen GS., et al. “Antioxidant and anti-inflammatory properties of an aqueous Cyanophyta extract derived from Arthrospira platensis: contribution to bioactivities by the non-phycocyanin aqueous fraction”. Journal of Medicinal Food 5 (2015): 535-541. https://pubmed.ncbi.nlm.nih.gov/25764268/
  59. Bernstein JA., et al. “Cyanobacteria: an unrecognized ubiquitous sensitizing allergen?” Allergy and Asthma Proceedings: Medical Journals 2 (2011): 106-110. https://www.ingentaconnect.com/content/ocean/aap/2011/00000032/00000002/art00006;jsessionid=wlwhtxf78xnq.x-ic-live-01
  60. Lee TM., et al. “Anaphylaxis to Spirulina confirmed by skin prick test with ingredients of Spirulina tablets”. Food and Chemical Toxicology 74 (2014): 309-310. https://pubmed.ncbi.nlm.nih.gov/25445756/
  61. Al-Dhabi NA. “Heavy metal analysis in commercial Spirulina products for human consumption Saudi”. Journal of Biological Sciences4 (2013): 383-388. https://www.sciencedirect.com/science/article/pii/S1319562X13000430
  62. Savranoglu S and Tumer TB. “Inhibitory effects of Spirulina platensis on carcinogen-activating cytochrome P450 isozymes and potential for drug interactions”. International Journal of Toxicology 32 (2013): 376-384. https://pubmed.ncbi.nlm.nih.gov/24082030/
  63. Petrus M., et al. “First case report of anaphylaxis to spirulin: identification of phycocyanin as responsible allergen”. Allergy7 (2010): 924-925. https://pubmed.ncbi.nlm.nih.gov/19889119/
  64. Marles RJ., et al. “United States pharmacopeia safety evaluation of Spirulina”. Critical Reviews in Food Science and Nutrition 7 (2001): 593-604. https://pubmed.ncbi.nlm.nih.gov/21793723/
  65. US National Library of Medicine. Blue-green alga (2021). https://medlineplus.gov/druginfo/natural/923.html
  66. Savranoglu S and Tumer TB. “Inhibitory effects of Spirulina platensis on carcinogen-activating cytochrome P450 isozymes and potential for drug interactions”. International Journal of Toxicology 32 (2013): 376-384. https://pubmed.ncbi.nlm.nih.gov/24082030/
Citation: Kerna NA, Nwokorie U, Ortigas MAC, Chawla S, Pruitt KD, Flores JV, Holets HM, Carsrud NDV, Waugh S, Anderson II J. “The Numerous and Varied Applications of Spirulina in Medical Practice”. EC Clinical and Medical Case Reports 5.3 (2022): 100-111.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


July Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the July issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before July 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.